Abstract
Characteristics Affecting Durability and Tolerability of Imatinib in Patients Switched from Brand to Generic and Newly Diagnosed Patients Initially Prescribed Generic Imatinib for Chronic Myeloid Leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have